MYND Life Sciences Inc.

    MYND Life Sciences Inc.

    CCSE:MYND
    - -
    CAD
    - -
    - -
    MYND Life Sciences Inc.
    CSE:MYND
    (Canadian Securities Exchange)

    Recent

    price

    - -

    P/E

    ratio

    - -

    div

    yld

    - -

    ROIC.AI

    2021
    2022
    2023
    TTM
    CAD
    - -
    - -
    - -
    - -
    Revenue per Share
    -0.1
    -0.08
    -0.03
    -0.01
    Basic EPS, GAAP
    -0.07
    -0.04
    - -
    - -
    Free Cash Flow per Basic Share
    - -
    - -
    - -
    - -
    Dividend per Share
    - -
    -0.08
    -0.1
    -0.13
    Book Value per Share
    - -
    -0.08
    -0.1
    -0.13
    Tangible Book Value per Share
    45
    47
    47
    47
    Basic Weighted Avg Shares
    - -
    - -
    - -
    - -
    Sales/Revenue/Turnover
    - -
    - -
    - -
    -128,598,000
    Operating Margin (%)
    - -
    - -
    - -
    - -
    Depreciation Expense
    -4
    -4
    -2
    -1
    Net Income, GAAP
    - -
    - -
    - -
    - -
    Effective Tax Rate (%)
    - -
    - -
    - -
    -54,256,500
    Profit Margin (%)
    2
    -4
    -5
    -6
    Working Capital
    2
    - -
    - -
    - -
    LT Debt
    - -
    -4
    -5
    -6
    Total Equity
    - -
    - -
    - -
    - -
    Return on Invested Capital (%)
    - -
    - -
    - -
    0.76
    Return on Capital (%)
    - -
    - -
    - -
    - -
    Return on Common Equity (%)

    Capital Structure

    CAD

    •

    in mil. unless spec.
    Jan'24
    Apr'24
    Jul'24
    ST Debt
    3
    3
    3
    LT Borrowings
    - -
    - -
    - -
    LT Finance Leases
    - -
    - -
    - -
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    48
    48
    48
    Market Capitalization
    1
    2
    2

    Working Capital

    CAD

    •

    in mil. unless spec.
    Jan'24
    Apr'24
    Jul'24
    Total Current Assets
    1
    1
    1
    Cash, Cash Equivalents & STI
    - -
    - -
    - -
    Accounts Receivable, Net
    1
    1
    1
    Inventories
    - -
    - -
    - -
    Total Current Liabilities
    6
    6
    7
    Payables & Accruals
    3
    3
    4
    ST Debt
    3
    3
    3
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    CAD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    - -
    - -
    40.91%
    Free Cash Flow
    - -
    - -
    -89.1%
    Net Income, GAAP
    - -
    - -
    -57.45%
    Sales/Revenue/Turnover
    - -
    - -
    - -
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    - -
    - -
    - -
    - -
    - -
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    -0.03
    -0.02
    -0.02
    - -
    -0.08
    2023
    -0.02
    -0.01
    -0.01
    - -
    -0.03
    2024
    -0.01
    -0.01
    -0.01
    - -
    - -

    Quarterly Dividends Per Share

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    - -
    - -
    - -
    - -
    - -
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -
    Similar Companies
    Business